# OnCo record paper-siopel-4-dose-dense-cisplatin-high-risk-hepatoblastoma-zsiros-lancet-oncol-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-siopel-4-dose-dense-cisplatin-high-risk-hepatoblastoma-zsiros-lancet-oncol-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-siopel-4-dose-dense-cisplatin-high-risk-hepatoblastoma-zsiros-lancet-oncol-2013" ;
  schema:name "SIOPEL-4: dose-dense cisplatin-based chemotherapy and surgery for high-risk hepatoblastoma"@en ;
  schema:description "Weekly cisplatin with doxorubicin before surgery got almost every child with high-risk hepatoblastoma to respond and three quarters to complete removal of the tumour, with three-year survival of 83 percent in a group that previously did poorly."@en ;
  schema:url <https://onco.cc/key-papers/paper-siopel-4-dose-dense-cisplatin-high-risk-hepatoblastoma-zsiros-lancet-oncol-2013/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(13)70272-9>, <https://pubmed.ncbi.nlm.nih.gov/23831416/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(13)70272-9> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Zsiros J, Brugieres L, Brock P, et al." ;
  onco:cancers <https://onco.cc/cancers/hepatoblastoma/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:trials <https://onco.cc/trials/siopel-4/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .